Sygnus AG (manufacturing of unpackaged product, primary packaging, quality control; secondary packaging; batch release)

The drug is prescribed to adults for the treatment of multiple myeloma. It is used both in combination with other medicines (e.g., bortezomib, melphalan, prednisone, lenalidomide, or dexamethasone) and as monotherapy in cases of relapsed or refractory disease.

Dosage form: concentrate for infusion solution

ATC: L01XC24